Molecular and functional properties of human Plasmodium falciparum CSP C-terminus antibodies
O. E. Oludada, G. Costa, C. Burn Aschner, A. Obraztsova, K. Prieto, C. Canetta, S. L. Hoffmann, P. Kremsner, B. Mordmueller, R. Murugan, J.-P. Julien, E. A. Levashina, H. Wardemann
This study characterizes human antibodies targeting the PfCSP C-terminal domain, finding limited protective activity and suggesting exclusion from malaria vaccine design.
bioRxiv · Jan 19, 2023 · PreprintImmunology